1. Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19. Issue 3 (9th April 2021) Authors: Delaunois, Annie; Abernathy, Matthew; Anderson, Warren D.; Beattie, Kylie A.; Chaudhary, Khuram W.; Coulot, Julie; Gryshkova, Vitalina; Hebeisen, Simon; Holbrook, Mark; Kramer, James; Kuryshev, Yuri; Leishman, Derek; Lushbough, Isabel; Passini, Elisa; Redfern, Will S.; Rodriguez, Blanca; Rossman,... Journal: Clinical and translational science Issue: Volume 14:Issue 3(2021) Page Start: 1133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative. Issue 2 (27th August 2018) Authors: Li, Zhihua; Ridder, Bradley J.; Han, Xiaomei; Wu, Wendy W.; Sheng, Jiansong; Tran, Phu N.; Wu, Min; Randolph, Aaron; Johnstone, Ross H.; Mirams, Gary R.; Kuryshev, Yuri; Kramer, James; Wu, Caiyun; Crumb, William J.; Strauss, David G. Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 2(2019) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗